Urgent

Insulin autoimmune syndrome (Hirata disease)

Hypoglycaemia · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Autoimmune hypoglycaemia from autoantibodies to insulin, causing post-absorptive hypoglycaemia with very high insulin levels; linked to certain drugs (sulfhydryl-containing) and autoimmune disease.

Red flags

  • Severe or recurrent hypoglycaemia
  • Reduced conscious level
  • Seizures
  • Failure of dietary measures

Assessment

Differential diagnosis

  • Insulinoma
  • Factitious insulin administration
  • Sulfonylurea-induced hypoglycaemia
  • Non-islet cell tumour hypoglycaemia
  • Adrenal insufficiency

Investigations

  • Glucose with paired insulin and C-peptide
  • Insulin autoantibodies
  • Drug history (recent sulfhydryl drugs)
  • Screen for autoimmune disease
  • Imaging only if insulinoma suspected

Management

  • Treat acute hypoglycaemia
  • Confirm hypoglycaemia with paired samples (very high insulin, high antibodies)
  • Stop any implicated drug
  • Small frequent low-carbohydrate meals to prevent episodes
  • Corticosteroids for persistent cases (specialist)
  • Endocrinology referral

Drugs & doses

IV / oral glucose acutely
Corticosteroids (specialist)
Discontinue offending drug

Disposition

Admit for control; endocrinology.

Complications & pitfalls

  • Neuroglycopenic injury
  • Recurrent hypoglycaemia
  • Diagnostic confusion with insulinoma

Exam pearls

  • Extremely high insulin with detectable antibodies distinguishes it from insulinoma.
  • Often self-limiting once a triggering drug is stopped.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.